Market Price

0.56 

-0.02 -3.6%

as of Dec 18 '18

52 Week Range:

0.53 2.70


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Shineco, Inc., a holding company, through its subsidiaries, produces, distributes, and sells health and well-being focused plant-based products in China. It processes and distributes traditional Chinese herbal medicine products, as well as other pharmaceutical products directly to individual customers. The company also plants, processes, and distributes green and organic agricultural produce; and grows, cultivates, and sells yew trees that are used for the production of anti-cancer medication, as well as ornamental bonsai trees for purifying indoor air quality. In addition, it offers domestic and international logistics services for agricultural products. Further, the company develops and distributes specialized fabrics, textiles, health supplements, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum. The company sells its Chinese medicinal products and western medicines through wholesale customers under its proprietary brand name and Tenethealth trademark name; and its 13 Ankang retail pharmacies operating under the Sunsimiao Pharmacies name, as well as 66 pharmacies operated by third parties under the Ankang Longevity Group Pharmacy cooperatives name. Shineco, Inc. sells its decoction pieces on the Anhui Bozhou Chinese medicine transaction market to medical materials companies and Chinese patent medicine factories. The company sells its Luobuma textile products through distribution networks online through third party e-commerce Websites, such as Taobao, Tmall, and JD; and yew trees and agricultural products primarily through its sales personnel, and group and institutional sales. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. and changed its name to Shineco, Inc. in June 2005. Shineco, Inc. was founded in 1997 and is based in Beijing, China.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Equity (BVPS) 2.81
3.64
growth rate 29.5%
Earnings BIT 7.00
7.11
6.50
7.34
7.45
9.27
growth rate 1.5% -8.5% 12.9% 1.4% 24.5%
Avg.PE 10.10
6.87
1.70
growth rate -32.0% -75.3%
ROA 19.06
21.50
15.43
14.91
13.52
10.02
growth rate 12.8% -28.2% -3.4% -9.3% -25.9%
ROE 26.36
26.15
17.52
17.15
15.16
11.33
growth rate -0.8% -33.0% -2.1% -11.6% -25.3%
ROIC 22.32
23.53
16.33
16.11
14.46
10.92
growth rate 5.4% -30.6% -1.4% -10.2% -24.5%
Cur. Ratio 3.00
5.06
4.77
5.43
8.89
5.89
growth rate 68.7% -5.7% 13.8% 63.7% -33.8%
Quick Ratio 1.60
2.61
3.00
4.63
7.84
4.97
growth rate 63.1% 14.9% 54.3% 69.3% -36.6%
Leverage 1.38
1.12
1.15
1.15
1.10
1.16
growth rate -18.8% 2.7% 0.0% -4.4% 5.5%
Balance Sheet Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Acct.Receivable 2.00
4.03
10.83
7.90
15.85
15.48
growth rate 101.7% 168.5% -27.1% 100.7% -2.3%
Acct.Payable 1.00
0.04
0.17
0.26
0.16
2.27
growth rate -96.2% 355.2% 51.4% -39.2% 1,335.9%
Cur.Assets 17.00
19.09
28.26
35.05
44.73
56.16
growth rate 12.3% 48.0% 24.1% 27.6% 25.6%
Total Assets 31.00
42.22
52.13
57.05
68.29
83.10
growth rate 36.2% 23.5% 9.4% 19.7% 21.7%
Cash 2.00
3.09
6.06
22.01
23.15
31.49
growth rate 54.5% 96.0% 263.4% 5.2% 36.0%
Inventory 8.00
5.50
8.30
4.61
2.35
2.36
growth rate -31.2% 50.9% -44.5% -49.1% 0.8%
Cur.Liabilities 6.00
3.76
5.92
6.54
5.03
9.53
growth rate -37.4% 57.6% 10.4% -23.1% 89.4%
Liabilities 6.00
3.76
5.92
6.54
5.03
10.23
growth rate -37.4% 57.6% 10.4% -23.1% 103.3%
Equity 37.77
45.36
49.56
62.17
71.82
growth rate 20.1% 9.3% 25.5% 15.5%
Common Shares 19.00
19.00
19.00
19.00
21.00
21.00
growth rate 0.0% 0.0% 0.0% 10.5% 0.0%
Cash Flow Statement Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Capital Expenditures 3.00
1.12
0.10
0.50
0.05
1.76
growth rate -62.6% -91.0% 390.9% -90.0% 3,433.5%
Cash From OA -5.00
9.48
2.65
13.29
-2.74
9.85
growth rate 100.0% -72.1% 402.1% -100.0% 100.0%
FCF per Share 0.06
0.11
growth rate 83.3%
Sale Purchase of Stock 5.61
0.70
5.39
5.39
growth rate -87.5% 670.9% 0.0%
FCF -9.00
8.00
3.00
13.00
-3.00
8.00
growth rate 100.0% -62.5% 333.3% -100.0% 100.0%
Income Statement Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18
Sales 35.00
31.29
32.63
35.21
33.59
43.90
growth rate -10.6% 4.3% 7.9% -4.6% 30.7%
Op.Income 7.00
7.11
6.50
7.34
7.45
9.27
growth rate 1.5% -8.5% 12.9% 1.4% 24.5%
IBT 8.98
8.57
9.47
9.87
9.65
growth rate -4.6% 10.6% 4.2% -2.2%
Net Income 6.00
7.83
7.28
8.14
8.47
7.59
growth rate 30.5% -7.0% 11.8% 4.1% -10.4%
EPS 0.34
0.42
0.41
0.36
growth rate 23.5% -2.4% -12.2%
Gross Profit 10.00
9.67
10.43
11.17
10.82
14.89
growth rate -3.3% 7.8% 7.1% -3.2% 37.7%

Quarterly Statements

Item Name Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Earnings BIT 0.96
3.24
3.92
1.16
0.39
growth rate 238.2% 21.0% -70.5% -66.6%
Balance Sheet Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Acct.Receivable 13.71
16.05
24.86
15.48
17.45
growth rate 17.0% 54.9% -37.8% 12.7%
Acct.Payable 0.15
1.74
3.24
2.27
0.50
growth rate 1,092.3% 86.3% -30.0% -78.0%
Cur.Assets 47.37
52.03
61.31
56.16
57.12
growth rate 9.9% 17.8% -8.4% 1.7%
Total Assets 71.28
78.88
89.26
83.10
81.12
growth rate 10.7% 13.2% -6.9% -2.4%
Cash 27.73
29.35
28.43
31.49
31.24
growth rate 5.9% -3.1% 10.7% -0.8%
Inventory 2.29
2.50
2.77
2.36
2.30
growth rate 9.4% 10.5% -14.5% -2.6%
Cur.Liabilities 5.29
7.76
10.50
9.53
7.97
growth rate 46.6% 35.4% -9.3% -16.4%
Liabilities 5.29
7.76
10.51
10.23
8.67
growth rate 46.6% 35.4% -2.7% -15.3%
Equity 64.87
70.01
77.64
71.82
71.42
growth rate 7.9% 10.9% -7.5% -0.6%
Common Shares 0.02
0.02
0.02
0.02
0.02
growth rate 0.0% 1.0% 0.0% 8.0%
Cash Flow Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Capital Expenditures 0.01
1.16
0.56
0.04
0.05
growth rate 15,789.0% -51.7% -93.6% 46.2%
Cash From OA 3.69
4.10
-2.44
4.50
-0.50
growth rate 11.1% -100.0% 100.0% -100.0%
Sale Purchase of Stock
growth rate
FCF 3.68
2.94
-3.00
4.47
-0.55
growth rate -20.2% -100.0% 100.0% -100.0%
Income Statement Sep '17 Dec '17 Mar '18 Jun '18 Sep '18
Sales 7.81
14.13
13.34
8.61
7.59
growth rate 81.0% -5.6% -35.4% -11.9%
Op.Income 0.96
3.24
3.92
1.16
0.39
growth rate 238.2% 21.0% -70.5% -66.6%
IBT 1.54
3.89
4.75
-0.54
0.87
growth rate 152.6% 22.0% -100.0% 100.0%
Net Income 1.26
3.60
4.55
-1.82
0.63
growth rate 186.5% 26.5% -100.0% 100.0%
Gross Profit 2.10
4.84
5.28
2.67
2.12
growth rate 130.2% 8.9% -49.4% -20.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (51.52)

YOY Growth Grade:

D (43.40)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 1.70 1.70
EPS / Growth 0.33

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 17.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 17.5% 17.5% 17.5%
Future PE 0.01 1.14 12.22
Future EPS 1.65 1.65 1.65
Value Price
MOS %
0.00
-99.3%
0.46
-17.3%
4.98
788.9%
MOS Price 0.00 0.23 2.49
IRT 1.38 1.38 1.38

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.